Is America's Omicron playbook strong enough?

A new COVID-19 variant has arrived, and like with other strains before it, America's attack strategy is half-baked, Ed Yong argues in The Atlantic.
Why? Because societally, Yong writes, "policy makers have already cut themselves off from the tools needed to protect the populations they serve" — things like quarantines and mask mandates. Boosters might offer reasonable protection against infection, but only 17 percent of Americans have received them, and now, many are struggling to make appointments. People from rural, low-income, and minority communities will likely experience the greatest delays.
The Biden administration has also opted to make rapid tests reimbursable through health insurance rather than distribute the tests "en masse," which "doesn't address the need where it is greatest," medical geographer Arrianna Marie Planey told Yong; low-wage workers, who deal with a higher risk of infection, "are the least able to afford tests up front and the least likely to have insurance."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And though control measures used for other variants — "masks, better ventilation, contact tracing, quarantine, and restrictions on gatherings" — should, in theory, work for Omicron too, "the U.S. has either failed to invest in these tools or has actively made it harder to use them."
America can't rely on just vaccines to get us out of the pandemic, Yong says. The U.S. attack arsenal must be strengthened with provisions like paid sick leave, stronger masks, improved ventilation, isolation capabilities, and "ways of retaining the frayed health-care workforce." Instead, however, we have "consistently dropped the ball" on many of these measures, neglecting to "build systems and enact policies that protect the health of entire communities" in favor of moving shot to shot.
"Self-interest is self-defeating," Yong argues, "and as long as its hosts ignore that lesson, the virus will keep teaching it."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Mountains of garbage are creating more hazards in Gaza
under the radar Gaza was already creating 1,700 tons of waste daily prior to the war
By Justin Klawans, The Week US Published
-
Sudoku medium: March 3, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Crossword: March 3, 2025
The Week's daily crossword
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published